CNP16-iminoquinone-SarsRdRp-mechanstic-study

An SGC Open Chemistry Networks Project (number 16) devoted to the target SARS-COV-2 RdRp, and specifically how the protein may be reacting with a series of iminiquinones that appear to inhibit the protein. Our current goal is to identify the site of cysteine modification: where is the SH group reacting on the iminoquinone, what is the structure of the adduct formed, how does the structure of the iminiquinone affect the reactivity and, perhaps, where on the protein the iminiquinone is attaching.

If this sounds interesting, and you agree to the simple RULES, you can get started. The current activity is in the Issues, with progress summarised on the wiki.

If you're here in response to the reach-out that requested help with modeling the reaction, go here.

For answers to all the questions you have, go to the FAQs.

Everything is open, with all content governed by a CC-BY-4.0 licence.

If you'd like to contact someone to talk about contributing, then write something in an Issue (see the tab above), which is a good way to communicate openly. (Issues describe what currently needs doing and act as a discussion forum - you need a Github account but it's super easy and not spammy. There's also an email address (chemistry@thesgc.org) you can use to ask questions. You can read more about all this in the "How To" area

Some humans involved in this Open Chemistry Networks Project:
Professor Matthew Todd, UCL, Head of Chemistry Networks at the SGC (medchem) @mattodd
Dr Xin Qiu, UCL, Chemistry and Project Champion @qxsml
Professor Tim Willson, UNC Chapel Hill @tmw20653
Dr Anwar Hossain, UNC Chapel Hill @ahsgc
Dr Peter Brown, UNC Chapel Hill @toluene44

You can see other contributors in the Issues (tab above).

The Pharma Champion: Vacant.
The Sir James Murray Student Champion: Vacant.

The licence for the content of this project is, unless otherwise stated, and as for all OCN projects, CC-BY-4.0. This means you can do whatever you like with the project content, including making money, provided you cite the project.

This project is part of the SGC's Open Chemistry Networks initiative and the READDI-AViDD antiviral drug discovery initiative.